Volume 3, Issue 3: Best practices in identifying cirrhosis and HCC in patients infected with HBV – role of prediction models
e-ViralHepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 3, Issue 3)
Nurses and health care professionals involved in the care of patients with Hepatitis.
After participating in this activity, the participant will demonstrate the ability to:
- Identify which patients with chronic hepatitis B virus (HBV) infection have high risk for cirrhosis and hepatocellular carcinoma (HCC)
- Outline the utility and limitations of prediction models for cirrhosis and HCC in patients with chronic HBV infection
- Describe how to incorporate predicted risk of HCC into decisions regarding hepatitis B treatment
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Disease and Gastroenterology/Hepatology
The Johns Hopkins University School of Medicine
- 1.00 ANCC